Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 634 A shares, $96.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | AGILENT TECHNOLOGIES, INC. (A) | Sale | 634 | $96.0K |
| Jul 6, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 22,862 | n/a |
| Jun 2, 2026 | AGILENT TECHNOLOGIES, INC. (A) | Sale | 1,600 | $216.7K |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Tender of Shares | 14,312 | n/a |
| Mar 23, 2026 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 2,158 | $241.2K |
| Mar 3, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 14,312 | n/a |
| Dec 3, 2025 | AGILENT TECHNOLOGIES, INC. (A) | Sale | 2,600 | $389.5K |
| Jul 18, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 30,000 | n/a |
| Apr 24, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Other (see footnotes) | 14,220 | n/a |
| Mar 18, 2025 | AGILENT TECHNOLOGIES, INC. (A) | Grant/Award | 1,819 | $220.4K |